newsfilter
← Latest News
GlobeNewswire·

Talaris Therapeutics Announces Upcoming Presentations at American Transplant Congress

Data to be presented include real-world evidence analysis of health outcomes among Phase 2 patients compared to matched controls Updated data on Phase 2 study follow-up, COVID-19 patient outcomes also planned for ATC BOSTON and LOUISVILLE, Ky., Ma